Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in Italy

INTRODUCTION: Emtricitabine/rilpivirine/tenofovir (EVP) is a fixed-dose combination of antiretrovirals (ARV) approved by the European Medicines Agency in November 2011 and introduced in Italy in February 2013. It is a once-a-day single tablet and is licensed in Europe for use only in ARV-naïve patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Cozzi-Lepri, Alessandro, Lo Caputo, Sergio, Maggiolo, Franco, Antinori, Andrea, Ammassari, Adriana, Marchetti, Giulia, Mastroianni, Claudio, Gori, Andrea, Di Perri, Giovanni, Angarano, Gioacchino, Carbone, Alessia, d'Arminio Monforte, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P243
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225399/
https://www.ncbi.nlm.nih.gov/pubmed/25397519
http://dx.doi.org/10.7448/IAS.17.4.19775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225399/
https://www.ncbi.nlm.nih.gov/pubmed/25397519
http://dx.doi.org/10.7448/IAS.17.4.19775

Ejemplares similares